Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.
Ciabatti E, Valetto A, Bertini V, Ferreri MI, Guazzelli A, Grassi S, Guerrini F, Petrini I, Metelli MR, Caligo MA, Rossi S, Galimberti S.
Ciabatti E, et al. Among authors: valetto a.
Oncotarget. 2017 Mar 25;8(45):79188-79200. doi: 10.18632/oncotarget.16578. eCollection 2017 Oct 3.
Oncotarget. 2017.
PMID: 29108298
Free PMC article.